The Merck & Co-backed antibody developer had secured $100m in equity and debt but has withdrawn plans for an IPO that would have raised $54m at the top of its range.

HealthReveal, the developer of an analytics platform that monitors the conditions of chronic disease sufferers, has secured $10.8m in a round led by GE Ventures.

Johnson & Johnson has invested in SuperX, the antibody developer founded by the executive team of XO1, which was acquired by subsidiary Janssen Pharmaceuticals in 2015.

Sodexo Ventures has invested in health and coaching platform developer LifeDojo as part of a $5.1m round closed alongside a strategic partnership with another Sodexo subsidiary.

Michael Anstey, formerly a principal at Boston Consulting Group, has joined university venturing fund Cambridge Innovation Capital to focus on the healthcare sector.